G
Giovannella Palmieri
Researcher at University of Naples Federico II
Publications - 160
Citations - 2609
Giovannella Palmieri is an academic researcher from University of Naples Federico II. The author has contributed to research in topics: Thymoma & Chemotherapy. The author has an hindex of 27, co-authored 151 publications receiving 2324 citations. Previous affiliations of Giovannella Palmieri include Regione Campania.
Papers
More filters
Journal ArticleDOI
Phase II Study of Sorafenib in Patients With Sunitinib-Refractory Metastatic Renal Cell Cancer
Giuseppe Di Lorenzo,Giacomo Cartenì,Riccardo Autorino,Gianni Bruni,Marianna Tudini,Mimma Rizzo,Michele Aieta,Antonio Gonnella,Pasquale Rescigno,Sisto Perdonà,Gianluca Giannarini,Sandro Pignata,Nicola Longo,Giovannella Palmieri,Ciro Imbimbo,Michele De Laurentiis,Vincenzo Mirone,Corrado Ficorella,Sabino De Placido +18 more
TL;DR: Although well tolerated, sorafenib shows limited efficacy in sunitinib-refractory MRCC and further randomized trials compared with other drugs that target different biologic pathways are needed to define the best second-line treatment option in these patients.
Journal ArticleDOI
Phase II Study of Everolimus in Patients With Thymoma and Thymic Carcinoma Previously Treated With Cisplatin-Based Chemotherapy
Paolo Andrea Zucali,Tommaso De Pas,Giovannella Palmieri,Adolfo Favaretto,Antonio Chella,Marcello Tiseo,Michele Caruso,Matteo Simonelli,Matteo Perrino,Fabio De Vincenzo,Francesca Toffalorio,Vincenzo Damiano,Giulia Pasello,Erika Garbella,M. Ali,Fabio Conforti,Margaret Ottaviano,Angela Cioffi,Sabino De Placido,Laura Giordano,Monica Bertossi,Annarita Destro,Luca Di Tommaso,Armando Santoro +23 more
TL;DR: Everolimus may induce durable disease control in a high percentage of patients with T or TC, albeit with a potential high risk of fatal pneumonitis, as evaluated in a single-arm, single-stage, open-label, multicenter, phase II trial.
Journal ArticleDOI
Successful treatment of a patient with a thymoma and pure red-cell aplasia with octreotide and prednisone.
Giovannella Palmieri,Secondo Lastoria,Annamaria Colao,Emilia Vergara,P. Varrella,E Biondi,Carmine Selleri,Lucio Catalano,Gaetano Lombardi,Angelo Raffaele Bianco,Marco Salvatore +10 more
TL;DR: A high uptake of indium-labeled octreotide (111In-DTPA-d-Phe1-octreotide) in thymomas, a phenomenon related to the high content of somatostatin receptors in these tumors, is demonstrated.
Journal Article
In vivo detection of malignant thymic masses by indium-111-DTPA-D-Phe1-octreotide scintigraphy.
Secondo Lastoria,Emilia Vergara,Giovannella Palmieri,Wanda Acampa,P. Varrella,Corradina Caraco,Raffaele A. Bianco,Pietro Muto,Marco Salvatore +8 more
TL;DR: In patients with myasthenia gravis, SRS may have a role in characterizing thymic masses, thereby overcoming the limits of cross-sectional imaging modalities.
Journal ArticleDOI
Phase II study of gefitinib in combination with docetaxel as first-line therapy in metastatic breast cancer
Fortunato Ciardiello,Teresa Troiani,F. Caputo,M. De Laurentiis,Giampaolo Tortora,Giovannella Palmieri,F. De Vita,M. R. Diadema,Michele Orditura,G. Colantuoni,C. Gridelli,Giuseppe Catalano,S. De Placido,Andrea Bianco +13 more
TL;DR: The activity and safety of gefitinib, a small-molecule epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor in combination with docetaxel as first-line treatment of women with metastatic breast cancer was evaluated.